Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pule

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Cancer Discovery|August 5, 2018
CAR T-cell Integration of Multiple Input Signals Allows for Precise Targeting of CancerDaniela Achkova, Martin Pule
British Journal of Haematology|March 11, 2015
CD19 chimeric antigen receptor T cell therapy for haematological malignanciesSara Ghorashian, Martin Pule, Persis Amrolia
Current Opinion in Molecular Therapeutics|November 19, 2002
Genetically engineered T-cells for adoptive immunotherapyMartin Pule, Catherine M Bollard, Helen E Heslop
Biomedical Optics Express|December 4, 2013
In vitro characterization of genetically expressed absorbing proteins using photoacoustic spectroscopyJan Laufer, Amit Jathoul, Martin Pule, et al.
Oncoimmunology|March 26, 2019
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccinationJon Amund Kyte, Anne Fåne, Martin Pule, et al.
Plos One|April 1, 2016
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other CancersSimon Thomas, Karin Straathof, Nourredine Himoudi, et al.
Plos One|November 5, 2015
Flow-Based Single Cell Deposition for High-Throughput Screening of Protein LibrariesCassandra Stowe, Arnold Pizzey, Tammy Kalber, et al.
Trends in Molecular Medicine|May 23, 2012
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foeDavid E Gilham, Reno Debets, Martin Pule, et al.
Neurophotonics|May 17, 2019
Quantitative <i>in vivo</i> dual-color bioluminescence imaging in the mouse brainMarkus Aswendt, Stefanie Vogel, Cordula Schäfer, et al.
Blood|September 4, 2014
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cellsIda Ricciardelli, Michael Patrick Blundell, Jennifer Brewin, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Cancer Discovery|August 5, 2018
CAR T-cell Integration of Multiple Input Signals Allows for Precise Targeting of CancerDaniela Achkova, Martin Pule
British Journal of Haematology|March 11, 2015
CD19 chimeric antigen receptor T cell therapy for haematological malignanciesSara Ghorashian, Martin Pule, Persis Amrolia
Current Opinion in Molecular Therapeutics|November 19, 2002
Genetically engineered T-cells for adoptive immunotherapyMartin Pule, Catherine M Bollard, Helen E Heslop
Biomedical Optics Express|December 4, 2013
In vitro characterization of genetically expressed absorbing proteins using photoacoustic spectroscopyJan Laufer, Amit Jathoul, Martin Pule, et al.
Oncoimmunology|March 26, 2019
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccinationJon Amund Kyte, Anne Fåne, Martin Pule, et al.
Plos One|April 1, 2016
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other CancersSimon Thomas, Karin Straathof, Nourredine Himoudi, et al.
Plos One|November 5, 2015
Flow-Based Single Cell Deposition for High-Throughput Screening of Protein LibrariesCassandra Stowe, Arnold Pizzey, Tammy Kalber, et al.
Trends in Molecular Medicine|May 23, 2012
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foeDavid E Gilham, Reno Debets, Martin Pule, et al.
Neurophotonics|May 17, 2019
Quantitative <i>in vivo</i> dual-color bioluminescence imaging in the mouse brainMarkus Aswendt, Stefanie Vogel, Cordula Schäfer, et al.
Blood|September 4, 2014
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cellsIda Ricciardelli, Michael Patrick Blundell, Jennifer Brewin, et al.
Pageof 8